Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients

References

• Scollard DM, Adams LB, Gillis TP, et al. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19(2):338–3381.
   PubMed Web of Science ®Google Scholar
• Sun PW, Wang L, Yu MW, et al. Leprosy statistics in China, 2017. Int J Dermatol Venereol. 2019;2(1):1–5.
   Google Scholar
• Cambau E, Saunderson P, Matsuoka M, et al. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15. Clin Microbiol Infect. 2018;24(12):1305–1310.
   PubMed Web of Science ®Google Scholar
• Dallas WS, Gowen JE, Ray PH, et al. Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100. J Bacteriol. 1992;174(18):5961–5970.
   PubMed Web of Science ®Google Scholar
• Ebenezer GJ, Norman G, Joseph GA, et al. Drug resistant-Mycobacterium leprae–results of mouse footpad studies from a laboratory in south India. Indian J Lepr. 2002;74(4):301–312.
   PubMedGoogle Scholar
• Cambau E, Perani E, Guillemin I, et al. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet. 1997;349(9045):103–104.
   PubMed Web of Science ®Google Scholar
• Comas I, Borrell S, Roetzer A, et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet. 2011;44(1):106–110.
   PubMed Web of Science ®Google Scholar
• Benjak A, Avanzi C, Singh P, et al. Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae. Nat Commun. 2018;9(1):352.
   PubMed Web of Science ®Google Scholar
• Malik S, Willby M, Sikes D, et al. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations. PLoS One. 2012;7:e39754.
   PubMed Web of Science ®Google Scholar
• Shen J, Liu M, Zhang J, et al. Relapse in MB leprosy patients treated with 24 months of MDT in south west China: a short report. Lepr Rev. 2006;77(3):219–224.
   PubMed Web of Science ®Google Scholar
• Guerrero MI, Muvdi-Arenas S, León-Franco CI. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia. Lepr Rev. 2012;83(3):247–260.
   PubMed Web of Science ®Google Scholar
• Beltrán-Alzate C, López Díaz F, Romero-Montoya M, et al. Leprosy drug resistance surveillance in Colombia: The Experience of a Sentinel Country. PLoS Negl Trop Dis. 2016;10(10):e0005041.
   PubMed Web of Science ®Google Scholar
• Job CK, Jayakumar J, Aschhoff M, et al. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy. Int J Lepr Other Mycobact Dis. 1996;64(1):44–50.
   PubMedGoogle Scholar
• Hasanoor Reja AH, Biswas N, Biswas S, et al. Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India. Indian J Dermatol Venereol Leprol. 2015;81(2):155–261.
   PubMed Web of Science ®Google Scholar
• Sekar B, Arunagiri K, Kumar BN, et al. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing–a rapid tool for screening drug resistance in leprosy. Lepr Rev. 2011;82(1):36–45.
   PubMed Web of Science ®Google Scholar
• Lavania M, Jadhav RS, Chaitanya VS, et al. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The leprosy Mission (TLM) Hospitals in India. Lepr Rev. 2014;85(3):177–185.
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Suzuki Y, Garcia IE, et al. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico. Jpn J Infect Dis. 2010;63(6):412–416.
   PubMed Web of Science ®Google Scholar
• Sapkota BR, Ranjit C, Neupane KD, et al. Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae. J Med Microbiol. 2008;57(2):179–184.
   PubMed Web of Science ®Google Scholar
• Balagon MF, Cellona RV, Cruz E, et al. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. Am J Trop Med Hyg. 2009;81(5):895–899.
   PubMed Web of Science ®Google Scholar
• Weng X, Wang Z, Liu J, et al. Identification and distribution of Mycobacterium leprae genotypes in a region of high leprosy prevalence in China: a 3-year molecular epidemiological study. J Clin Microbiol. 2007;45(6):1728–1734.
   PubMed Web of Science ®Google Scholar
• Jadhav RS, Kamble RR, Shinde VS, et al. Use of reverse transcription polymerase chain reaction for the detection of Mycobacterium leprae in the slit-skin smears of leprosy patients. Indian J Lepr. 2005;77(2):116–127.
   PubMedGoogle Scholar
• Kimura M, Sakamuri RM, Groathouse NA, et al. Rapid variable-number tandem-repeat genotyping for Mycobacterium leprae clinical specimens. J Clin Microbiol. 2009;47(6):1757–1766.
   PubMed Web of Science ®Google Scholar
• Lavania M, Singh I, Turankar RP, et al. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients. J Glob Antimicrob Resist. 2018;12:214–219.
   PubMed Web of Science ®Google Scholar
• You EY, Kang TJ, Kim SK, et al. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea. J Infect. 2005;50(1):6–11.
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Budiawan T, Aye KS, et al. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr Rev. 2007;78(4):343–352.
   PubMed Web of Science ®Google Scholar
• Kai M, Nguyen Phuc NH, Nguyen HA, et al. Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam. Clin Infect Dis. 2011;52(5):127–132.
   Web of Science ®Google Scholar
• Liu D, Zhang Q, Sun Y, et al. Drug resistance in Mycobacterium leprae from patients with leprosy in China. Clin Exp Dermatol. 2015;40(8):908–911.
   PubMed Web of Science ®Google Scholar
• Contreras Mejía Mdel C, Porto Dos Santos M, Villarouco da Silva GA, et al. Identification of primary drug resistance to rifampin in Mycobacterium leprae strains from leprosy patients in Amazonas State, Brazil. J Clin Microbiol. 2014;52(12):4359–4360.
   PubMed Web of Science ®Google Scholar
• Da Silva Rocha A, Cunha M, Diniz LM, et al. Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients. J Clin Microbiol. 2012;50(6):1912–1917.
   PubMed Web of Science ®Google Scholar
• Singh P, Busso P, Paniz-Mondolfi A, et al. Molecular drug susceptibility testing and genotyping of Mycobacterium leprae strains from South America. Antimicrob Agents Chemother. 2011;56(6):2971–2983.
   Web of Science ®Google Scholar
• Shen JP, Gupte MD, Jiang C, et al. Trends of case detection and other indicators of leprosy in China during 1985–2002. Chin Med Sci J. 2005;20(2):77–82.
   PubMedGoogle Scholar
• Jing Z, Zhang R, Zhou D, et al. Twenty-five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Lepr Rev. 2009;80(2):170–186.
   PubMed Web of Science ®Google Scholar
• Shen J, Yan L, Sun P. Clinical features of relapse after multidrug therapy for leprosy in China. Lepr Rev. 2015;86(2):165–179.
   PubMed Web of Science ®Google Scholar
• Xiao YH, Wang J, Li Y. Bacterial resistance surveillance in China: a report from Mohnarin 2004–2005. Eur J Clin Microbiol Infect Dis. 2008;27:697–708.
   PubMed Web of Science ®Google Scholar
• Fontana C1, Favaro M, Minelli S, et al. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother. 2002;46(2):3765–3769.
   PubMed Web of Science ®Google Scholar
• De Francesco V1, Zullo A, Giorgio F, et al. Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. J Med Microbiol. 2014;63(3):453–467.
   PubMed Web of Science ®Google Scholar
• Gunawan H, Sasmojo M, Putri HE, et al. Clinical pilot study: clarithromycin efficacy in multibacillary leprosy therapy. Int J Mycobacteriol. 2018;7(2):152–155.
   PubMed Web of Science ®Google Scholar
• Smith CM, Maguire H, Anderson C, et al. Multiple large clusters of tuberculosis in London: a cross-sectional analysis of molecular and spatial data. ERJ Open Res. 2017;3(1):00098–02016.
   PubMedGoogle Scholar